Search dm+d | This AMP cannot be matched against our prescribing data.
| Description | Nulojix 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) |
| BNF code | 0802020Y0BBAAAA |
| Virtual Medicinal Product | Belatacept 250mg powder for solution for infusion vials |
| Name | Nulojix 250mg powder for concentrate for solution for infusion vials |
| Abbreviated name | Nulojix 250mg pdr for concentrate for inf vials |
| Supplier | Bristol-Myers Squibb Pharmaceuticals Ltd |
| Current licensing authority | Medicines - MHRA/EMA |
| EMA additional monitoring | ✗ |
| Parallel import | ✗ |
| Restrictions on availability | None |
| Licensed Route | |
|---|---|
| Licenced route | Intravenous |
| Actual Medicinal Product Packs | |
| Nulojix 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial | |
| Nulojix 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 2 vial | |
dm+d data retrieved from TRUD: release NHSBSA_4.3.0_20240422000001, imported on 22nd April 2024 at 05:06:50.